Japanese CRO SNBL's Satoshi Matsumoto On Japan's Clinical Trial Drain: An Interview with PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Shin Nippon Biomedical Laboratories is one of the largest contract research organizations in Japan, originating from Kagoshima at the southern end of Kyushu Island.
You may also be interested in...
Forget China And India, Clinical Trial Opportunities In Malaysia and South Korea
The opportunities for clinical trials in China and India are well known to the pharmaceutical industry at this point, but Edward Ian, senior director of clinical operations for PRA International-Asia Pacific, wants company leaders to take notice and advantage of the potential in other countries in Asia Pacific
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).